StockData
Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc. (EVFM) stock

EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.01−0.00 (-10.00%)

Close on Oct 19, 2026Market cap $865.23KP/E –Yield –

Evofem Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Evofem Biosciences's market cap was $834.94K on Oct 19, 2026, against $1.13M a year earlier. Over the last 5 years it ranged from $68.15K to $78.49M, with a median of $1.09M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$834.94K-29.1%
2025Dec 31, 2025$1.18M+18.6%
2024Dec 31, 2024$993.25K+514.8%
2023Dec 29, 2023$161.55K-97.5%
2022Dec 30, 2022$6.53M-88.8%
2021Dec 31, 2021$58.36M-70.2%
2020Dec 31, 2020$195.88M-32.1%
2019Dec 31, 2019$288.70M+166.2%
2018Dec 31, 2018$108.46M+302.3%
2017Dec 29, 2017$26.96M+74.1%
2016Dec 30, 2016$15.49M-18.7%
2015Dec 31, 2015$19.05M+392.0%
2014Dec 31, 2014$3.87M–

More Evofem Biosciences figures

See a number that looks wrong?